Jackie Hunter
2010
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Jackie Hunter trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Jackie Hunter's perspective
Ordered by how strongly the researchers Jackie Hunter trusts endorse each paper. Same corpus, a different order for every researcher.
- Open Innovation: The New Imperative for Creating and Profiting from Technology
- Can open-source R&D reinvigorate drug research?
- The price of innovation: new estimates of drug development costs.
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
- The druggable genome (Nature reviews. Drug discovery)
- The Black Swan: The Impact of the Highly Improbable
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
- PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (Journal of Lipid Research)
- Seeing What's Next: Using the Theories of Innovation to Predict Industry Change
- How open is innovation
Their papers
- Is open innovation the way forward for big pharma? (2010) — 137 citations